Putting the treatment of paediatric schistosomiasis into context

by Takafira Mduluza and Francisca Mutapi
Infectious Diseases of Poverty (2017) 6:85

6 pp. 507 kB
https://idpjournal.biomedcentral.com/track/pdf/10.1186/s40249-017-0300-8?
site=idpjournal.biomedcentral.com

Despite increased international efforts to control schistosomiasis using preventive chemotherapy, several challenges still exist in reaching the target populations. Until recently, preschool-aged children had been excluded from the recommended target population for mass drug administration, i.e. primary school children aged 6–15 years. Our studies and those of others provided the evidence base for the need to treat preschool-aged children that led to recommendations by the World Health Organization to include preschool-aged children in treatment programmes in 2010. The major challenge now lies in the unavailability of a child-size formulation of the appropriate anthelmintic drug, praziquantel.

(Visited 6 times, 1 visits today)
This entry was posted in General, Maternal & Child Health, Other Infectious Diseases. Bookmark the permalink.